Kiromic BioPharma, Inc.
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The com…
Biotechnology
US, Houston [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Kiromic BioPharma, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDKiromic BioPharma, Inc. can't present revenue by segment